Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:54:57 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



News for U:XSNX from 2023-05-08 to 2024-05-07 - 11 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-07 11:58U:XSNXNews ReleaseNovAccess Global Advisory on Annual Meeting of Shareholders
2024-04-30 09:05U:XSNXNews ReleaseNovAccess Global Announces New License to Advance its Immunotherapy Platform
2024-03-01 09:03U:XSNXNews ReleaseNovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
2024-01-02 08:02U:XSNXNews ReleaseNovAccess Global Announces $10.7 Million Financing
2023-12-01 16:52U:XSNXNews ReleaseNovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
2023-11-10 09:02U:XSNXNews ReleaseNovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
2023-07-27 08:31U:XSNXNews ReleaseNovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
2023-07-13 08:32U:XSNXNews ReleaseNovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
2023-06-16 12:40U:XSNXNews ReleaseNovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
2023-06-01 08:42U:XSNXNews ReleaseNovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
2023-05-11 09:08U:XSNXNews ReleaseNovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements